Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
immune response
|
| gptkbp:administeredBy |
Rh-negative pregnant women
|
| gptkbp:alsoKnownAs |
gptkb:Rho(D)_immune_globulin
|
| gptkbp:approvedBy |
gptkb:FDA
|
| gptkbp:ATCCode |
gptkb:J06BB01
|
| gptkbp:contraindication |
Rh-positive individuals
|
| gptkbp:developedBy |
1960s
|
| https://www.w3.org/2000/01/rdf-schema#label |
Anti-D
|
| gptkbp:includedIn |
gptkb:WHO_Model_List_of_Essential_Medicines
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
binds to Rh(D) positive fetal red blood cells
|
| gptkbp:prevention |
hemolytic disease of the newborn
maternal sensitization to Rh(D) antigen |
| gptkbp:producedBy |
human plasma
|
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
fever
allergic reaction injection site pain |
| gptkbp:usedFor |
prevention of Rh disease
|
| gptkbp:usedIn |
obstetrics
transfusion medicine |
| gptkbp:bfsParent |
gptkb:This_Modern_Glitch
gptkb:Bloodgroup |
| gptkbp:bfsLayer |
7
|